A new drug for the neglected disease sleeping sickness is currently in clinical trials; if the trials are conclusive, Fexinidazole could be registered within two years and sleeping sickness could be eradicated around 2020. This drug would be a vast improvement over current treatment as it's much simpler to administer and thus accessible to many more people. Doctors Without Borders/Médecins Sans Frontières (MSF) and other partner organizations established Drugs for Neglected Diseases Initiative (DNDi) in 2003 to develop new treatments for neglected diseases, including sleeping sickness.
Be part of MSF
Our supporters, donors, and fundraisers are a vital part of the MSF movement.
Find out how you can support MSF's lifesaving work.